ALOX15 and asthma: Then, ECRSwNP patients were more likely to have asthma (P = 0.003), allergic rhinitis (P = 0.044) and atopy (P = 0.034) (Table 1), as well as higher ALOX15 mRNA levels in nasal polyp tissues (P < 0.001) (Fig. 1).